Table of Contents Author Guidelines Submit a Manuscript
Journal of Analytical Methods in Chemistry
Volume 2013, Article ID 132836, 9 pages
http://dx.doi.org/10.1155/2013/132836
Research Article

Microemulsion Liquid Chromatographic Method for Simultaneous Determination of Simvastatin and Ezetimibe in Their Combined Dosage Forms

Department of Medicinal Chemistry, Faculty of Pharmacy, University of Mansoura, Mansoura 35516, Egypt

Received 5 May 2013; Revised 4 August 2013; Accepted 8 August 2013

Academic Editor: Juan F. Garcia-Reyes

Copyright © 2013 Mohammed E. A. Hammouda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. C. Moffat, M. D. Osselton, B. Widdop, and L. Y. Galichet, Eds., Clarke's Analysis of Drugs and Poisons, The Pharmaceutical Press, London, UK, 4th edition, 2011.
  2. S. C. Sweetman, Ed., Martindale: The Complete Drug Reference, The Pharmaceutical Press, London, UK, 35th edition, 2007.
  3. M. M. Sharaf El-Din, K. A. Attia, M. W. Nassar, and M. M. Kaddah, “Colorimetric determination of simvastatin and lovastatin in pure form and in pharmaceutical formulations,” Spectrochimica Acta A, vol. 76, no. 3-4, pp. 423–428, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Erk, “Rapid spectrophotometric method for quantitative determination of simvastatin and fluvastatin in human serum and pharmaceutical formulations,” Die Pharmazie, vol. 57, no. 12, pp. 817–819, 2002. View at Google Scholar · View at Scopus
  5. L. Wang and M. Asgharnejad, “Second-derivative UV spectrometric determination of simvastatin in its tablet dosage form,” Journal of Pharmaceutical and Biomedical Analysis, vol. 21, no. 6, pp. 1243–1248, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. Ö. Coruh and S. A. Özkan, “Determination of the antihyperlipidemic simvastatin by various voltammetric techniques in tablets and serum samples,” Die Pharmazie, vol. 61, no. 4, pp. 285–290, 2006. View at Google Scholar · View at Scopus
  7. M. K. Srinivasu, A. N. Raju, and G. O. Reddy, “Determination of lovastatin and simvastatin in pharmaceutical dosage forms by MEKC,” Journal of Pharmaceutical and Biomedical Analysis, vol. 29, no. 4, pp. 715–721, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Nováková, H. Vlcková, D. Satínský et al., “Ultra high performance liquid chromatography tandem mass spectrometric detection in clinical analysis of simvastatin and atorvastatin,” Journal of Chromatography B, vol. 877, no. 22, pp. 2093–2103, 2009. View at Google Scholar
  9. T. D. Silva, M. A. Oliveira, R. B. de Oliveira, and C. D. Vianna-Soares, “Development and validation of a simple and fast HPLC method for determination of lovastatin, pravastatin and simvastatin,” Journal of Chromatographic Science, vol. 50, no. 9, pp. 831–838, 2012. View at Google Scholar
  10. L. Burugula, R. Mullangi, N. R. Pilli, A. Makula, D. S. Lodagala, and R. Kandhagatla, “Simultaneous determination of sitagliptin and simvastatin in human plasma by LC-MS/MS and its application to a human pharmacokinetic study,” Biomedical Chromatography, vol. 27, no. 1, pp. 80–87, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. N. R. Pilli, R. Mullangi, J. K. Inamadugu, I. K. Nallapati, and J. V. Rao, “Simultaneous determination of simvastatin, lovastatin and niacin in human plasma by LC-MS/MS and its application to a human pharmacokinetic study,” Biomedical Chromatography, vol. 26, no. 4, pp. 476–484, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Zhang, R. Rodila, E. Gage et al., “High-throughput salting-out assisted liquid/liquid extraction with acetonitrile for the simultaneous determination of simvastatin and simvastatin acid in human plasma with liquid chromatography,” Analytica Chimica Acta, vol. 661, no. 2, pp. 167–172, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Sharma, D. V. Mhaske, M. Mahadik, S. S. Kadam, and S. R. Dhaneshwar, “UV and three derivative spectrophotometric methods for determination of ezetimibe in tablet formulation,” Indian Journal of Pharmaceutical Sciences, vol. 70, no. 2, pp. 258–260, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Imran, R. S. Singh, and S. Chandran, “Stability indicating ultraviolet spectroscopic method for the estimation of ezetimibe and carvedilol,” Die Pharmazie, vol. 61, no. 9, pp. 766–769, 2006. View at Google Scholar · View at Scopus
  15. N. A. Alarfaj and F. A. Aly, “Micelle-enhanced spectrofluorimetric method for determination of cholesterol-reducing drug ezetimibe in dosage forms,” Journal of Fluorescence, vol. 22, no. 1, pp. 9–15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. L. Dalmora, P. R. Oliveira, T. Barth, and V. Todeschini, “Development and validation of a stability-indicating micellar electrokinetic chromatography method for the determination of ezetimibe in pharmaceutical formulations,” Analytical Sciences, vol. 24, no. 4, pp. 499–503, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Uçaktürk, N. Ozaltin, and B. Kaya, “Quantitative analysis of ezetimibe in human plasma by gas chromatography-mass spectrometry,” Journal of Separation Science, vol. 32, no. 11, pp. 1868–1874, 2009. View at Google Scholar
  18. A. Goel, S. Baboota, J. K. Sahni et al., “Development and validation of stability-indicating assay method by UPLC for a fixed dose combination of atorvastatin and ezetimibe,” Journal of Chromatographic Science, vol. 51, no. 3, pp. 222–228, 2012. View at Publisher · View at Google Scholar
  19. A. Ajmera, S. Deshpande, P. Patel, K. Patel, S. Solanki, and K. Rathod, “Reverse phase high performance liquid chromatographic (HPLC) method for simultaneous determination of atorvastatin, ezetimibe and fenofibrate in commercial tablets,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 4, no. 1, pp. 206–209, 2012. View at Google Scholar · View at Scopus
  20. A. Patel, C. Macwana, V. Parmar, and S. Patel, “Simultaneous determination of atorvastatin calcium, ezetimibe, and fenofibrate in a tablet formulation by HPLC,” Journal of AOAC International, vol. 95, no. 2, pp. 419–423, 2012. View at Google Scholar
  21. S. J. Varghese and T. K. Ravi, “Determination of rosuvastatin and ezetimibe in a combined tablet dosage form using high-performance column liquid chromatography and high-performance thin-layer chromatography,” Journal of AOAC International, vol. 93, no. 4, pp. 1222–1227, 2010. View at Google Scholar · View at Scopus
  22. B. G. Chaudhari, N. M. Patel, P. B. Shah, L. J. Patel, and V. P. Patel, “Stability-indicating reversed-phase liquid chromatographic method for simultaneous determination of atorvastatin and ezetimibe from their combination drug products,” Journal of AOAC International, vol. 90, no. 6, pp. 1539–1546, 2007. View at Google Scholar · View at Scopus
  23. S. J. Basha, S. A. Naveed, N. K. Tiwari et al., “Concurrent determination of ezetimibe and its phase-I and II metabolites by HPLC with UV detection: quantitative application to various in vitro metabolic stability studies and for qualitative estimation in bile,” Journal of Chromatography B, vol. 853, no. 1-2, pp. 88–96, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Singh, B. Singh, R. Bahuguna, L. Wadhwa, and R. Saxena, “Stress degradation studies on ezetimibe and development of a validated stability-indicating HPLC assay,” Journal of Pharmaceutical and Biomedical Analysis, vol. 41, no. 3, pp. 1037–1040, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Li, G. Liu, J. Jia, X. Li, and C. Yu, “Liquid chromatography-negative ion electrospray tandem mass spectrometry method for the quantification of ezetimibe in human plasma,” Journal of Pharmaceutical and Biomedical Analysis, vol. 40, no. 4, pp. 987–992, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Sistla, V. S. Tata, Y. V. Kashyap, D. Chandrasekar, and P. V. Diwan, “Development and validation of a reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage forms,” Journal of Pharmaceutical and Biomedical Analysis, vol. 39, no. 3-4, pp. 517–522, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. V. B. Mane, S. Babar, and N. Kulkarni, “Development of UV spectrophotometric method for the simultaneous estimation of simvastatine and ezetimibe in tablet dosage form by simultaneous equation and absorbance ratio method,” International Journal of PharmTech Research, vol. 3, no. 3, pp. 1459–1466, 2011. View at Google Scholar · View at Scopus
  28. H. M. Lotfy, A. M. Aboul Alamein, and M. A. M. Hegazy, “Quantitative analysis of the cholesterol-lowering drugs ezetimibe and simvastatin in pure powder, binary mixtures, and a combined dosage form by spectrophotometry, chemometry, and high-performance column liquid chromatography,” Journal of AOAC International, vol. 93, no. 6, pp. 1844–1855, 2010. View at Google Scholar · View at Scopus
  29. S. Balaji and A. Sunitha, “Development and validation of spectrophotometeric method for simultaneous determination of simvastatin and ezetimibe in tablet formulations,” Pakistan Journal of Pharmaceutical Sciences, vol. 23, no. 4, pp. 375–378, 2010. View at Google Scholar · View at Scopus
  30. H. M. Maher, R. M. Youssef, E. M. Hassan, E. I. El-Kimary, and M. A. Barary, “Enhanced spectrophotometric determination of two antihyperlipidemic mixtures containing ezetimibe in pharmaceutical preparations,” Drug Testing and Analysis, vol. 3, no. 2, pp. 97–105, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. I. M. Palabiyik, F. Onur, C. Yardimci, and N. Özaltin, “Simultaneous spectrophotometric determination of ezetimibe and simvastatin in pharmaceutical preparations using chemometric techniques,” Química Nova, vol. 31, no. 5, pp. 1121–1124, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Shrestha, B. Stephenrathinaraj, S. S. Patel, N. K. Verma, and R. Mazumder, “Simultaneous HPTLC estimation of simvastatin and ezetimibe in tablet dosage form,” E-Journal of Chemistry, vol. 7, no. 4, pp. 1206–1211, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. B. S. Rathinaraj, S. V. Kumar, S. Sudharshini, B. Thirupathy, and G. Vaagdevi, “Quantitative analysis of simvastatin and ezetimibe of drugs in combined dosage forms by HPLC,” International Journal of Pharma and Bio Sciences, vol. 1, no. 2, pp. 1–7, 2010. View at Google Scholar · View at Scopus
  34. R. P. Dixit, C. R. Barhate, S. G. Padhye, C. L. Viswanathan, and M. S. Nagarsenker, “Stability indicating RP-HPLC method for simultaneous determination of simvastatin and ezetimibe from tablet dosage form,” Indian Journal of Pharmaceutical Sciences, vol. 72, no. 2, pp. 204–210, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. P. R. Oliveira, T. Barth, V. Todeschini, and S. L. Dalmora, “Simultaneous liquid chromatographic determination of ezetimibe and simvastatin in pharmaceutical products,” Journal of AOAC International, vol. 90, no. 6, pp. 1566–1572, 2007. View at Google Scholar · View at Scopus
  36. E. W. Kaler and S. Prager, “A model of dynamic scattering by microemulsions,” Journal of Colloid and Interface Science, vol. 86, no. 2, pp. 359–369, 1982. View at Google Scholar · View at Scopus
  37. S. Torres Cartas, M. C. García Alvarez-Coque, and R. M. Villanueva Camañas, “Determination of anabolic steroids in pharmaceuticals by liquid chromatography with a microemulsion of sodium dodecyl sulfate and pentanol as mobile phase,” Analytica Chimica Acta, vol. 302, no. 2-3, pp. 163–172, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. D. T. M. El-Sherbiny, S. M. El-Ashry, M. A. Mustafa, A. A.-E. El-Emam, and S. H. Hansen, “Evaluation of the use of microemulsions as eluents in high-performance liquid chromatography,” Journal of Separation Science, vol. 26, no. 6-7, pp. 503–509, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Marsh, B. Clark, and K. Altria, “Oil-in-water microemulsion high performance liquid chromatographic analysis of pharmaceuticals,” Chromatographia, vol. 59, no. 9-10, pp. 531–542, 2004. View at Google Scholar · View at Scopus
  40. A. Malenovic, D. Ivanovic, M. Medenica, B. Jancic, and S. Markovic, “Retention modelling in liquid chromatographic separation of simvastatin and six impurities using a microemulsion as eluent,” Journal of Separation Science, vol. 27, no. 13, pp. 1087–1092, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. D. T. El-Sherbiny, M. I. Eid, D. R. El-Wasseef, R. M. Al-Ashan, and F. Belal, “Analysis of flunarizine in the presence of some of its degradation products using micellar liquid chromatography (MLC) or microemulsion liquid chromatography (MELC)—application to dosage forms,” Journal of Separation Science, vol. 28, no. 2, pp. 197–202, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. B. Jancic, D. Ivanovic, M. Medenica, A. Malenovic, and N. Dimkovic, “Development of liquid chromatographic method for fosinoprilat determination in human plasma using microemulsion as eluent,” Journal of Chromatography A, vol. 1088, no. 1-2, pp. 187–192, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. B. Jančić, M. Medenica, D. Ivanović, A. Malenović, and S. Marković, “Microemulsion liquid chromatographic method for characterisation of fosinopril sodium and fosinoprilat separation with chemometrical support,” Analytical and Bioanalytical Chemistry, vol. 383, no. 4, pp. 687–694, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Malenović, M. Medenica, D. Ivanović, and B. Jančić, “Monitoring of simvastatin impurities by HPLC with microemulsion eluents,” Chromatographia, vol. 63, no. 13, pp. S95–S100, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. D. T. El-Sherbiny, N. El-Enany, F. F. Belal, and S. H. Hansen, “Simultaneous determination of loratadine and desloratadine in pharmaceutical preparations using liquid chromatography with a microemulsion as eluent,” Journal of Pharmaceutical and Biomedical Analysis, vol. 43, no. 4, pp. 1236–1242, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. M. I. Walash, F. Belal, N. El-Enany, and A. Abdelal, “Microemulsion liquid chromatographic determination of nicardipine hydrochloride in pharmaceutical preparations and biological fluids. Application to stability studies,” Journal of Liquid Chromatography and Related Technologies, vol. 30, no. 8, pp. 1015–1034, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. E. McEvoy, S. Donegan, J. Power, and K. Altria, “Optimisation and validation of a rapid and efficient microemulsion liquid chromatographic (MELC) method for the determination of paracetamol (acetaminophen) content in a suppository formulation,” Journal of Pharmaceutical and Biomedical Analysis, vol. 44, no. 1, pp. 137–143, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Malenovic, B. Jancic-Stojanovic, M. Medenica, and D. Ivanovic, “Microemulsion liquid chromatographic screening of simvastatin and its active metabolite in human plasma,” Acta Chromatographica, vol. 20, no. 4, pp. 595–607, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. 2012, http://www.DrugBank.com/Simvastatin(DB00641).htm.
  50. ICH Harmonized Tripartite Guideline, “Validation of Analytical Procedures,” Text and Methodology, Q2(R1), Current Step 4 Version, Parent Guidelines on Methodology Dated November 6 1996, Incorporated in November 2005.
  51. J. N. Miller and J. C. B. Miller, Statistics and Chemometrics for Analytical Chemistry, Pearson Education Limited, Harlow, UK, 5th edition, 2005.